White blood cell global methylation and IL-6 promoter methylation in association with diet and lifestyle risk factors in a cancer-free population

Epigenetics

Volumn 7, Issue 6, 2012, Pages 606-614

  Zhang, Fang Fang ^a,b   Santella, Regina M ^c   Wolff, Mary ^d   Kappil, Maya A ^c   Markowitz, Steven B ^e   Morabia, Alfredo ^e  

^a TUFTS UNIVERSITY   (United States)

^b UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

^c Columbia University ^*  (United States)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^e CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

Cancer; Diet; DNA methylation; Lifestyle factors

Indexed keywords

C REACTIVE PROTEIN; FOLIC ACID;

ADULT; AGE; AGED; ANALYZER; ARTICLE; BODY MASS; DIET; DNA METHYLATION; ETHNICITY; FEMALE; FOOD INTAKE; GENDER; GENE; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; INTERLEUKIN 6 GENE; LEUKOCYTE; LIFESTYLE; LINE 1 GENE; MALE; PHYSICAL ACTIVITY; POPULATION RESEARCH; QUESTIONNAIRE; RISK FACTOR;

EID: 84861922071     PISSN: 15592294     EISSN: 15592308     Source Type: Journal    
DOI: 10.4161/epi.20236     Document Type: Article

References (49)

1. Yoo CB, Jones PA. Epigenetic therapy of cancer: past, present and future. Nat Rev Drug Discov 2006; 5:37-50.; PMID:16485345; http://dx.doi.org/10.1038/nrd1930.
2. Sharma S, Kelly TK, Jones PA. Epigenetics in cancer. Carcinogenesis 2010; 31:27-36.; PMID:19752007; http://dx.doi.org/10.1093/carcin/bgp220.
3. Wilson AS, Power BE, Molloy PL. DNA hypomethylation and human diseases. Biochim Biophys Acta 2007; 1775:138-62.; PMID:17045745.
4. Esteller M. CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future. Oncogene 2002; 21:5427-40.; PMID:12154405; http://dx.doi.org/10.1038/sj.onc.1205600.
5. Choi JY, James SR, Link PA, McCann SE, Hong CC, Davis W, et al. Association between global DNA hypomethylation in leukocytes and risk of breast cancer. Carcinogenesis 2009; 30:1889-97.; PMID:19584139; http://dx.doi.org/10.1093/carcin/bgp143.
6. Hou L, Wang H, Sartori S, Gawron A, Lissowska J, Bollati V, et al. Blood leukocyte DNA hypomethylation and gastric cancer risk in a high-risk Polish population. Int J Cancer 2010; 127:1866-74.; PMID:20099281; http://dx.doi.org/10.1002/ijc.25190.
7. Hsiung DT, Marsit CJ, Houseman EA, Eddy K, Furniss CS, McClean MD, et al. Global DNA methylation level in whole blood as a biomarker in head and neck squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 2007; 16:108-14.; PMID:17220338; http://dx.doi.org/10.1158/1055-9965.EPI-06-0636.
8. Lim U, Flood A, Choi SW, Albanes D, Cross AJ, Schatzkin A, et al. Genomic methylation of leukocyte DNA in relation to colorectal adenoma among asymptomatic women. Gastroenterology 2008; 134:47-55.; PMID:18166347; http://dx.doi.org/10.1053/j.gastro.2007.10.013.
9. Moore LE, Pfeiffer RM, Poscablo C, Real FX, Kogevinas M, Silverman D, et al. Genomic DNA hypomethylation as a biomarker for bladder cancer susceptibility in the Spanish Bladder Cancer Study: a case-control study. Lancet Oncol 2008; 9:359-66.; PMID:18339581; http://dx.doi.org/10.1016/S1470-2045(08)70038-X.
10. Pufulete M, Al-Ghnaniem R, Leather AJ, Appleby P, Gout S, Terry C, et al. Folate status, genomic DNA hypomethylation and risk of colorectal adenoma and cancer: a case control study. Gastroenterology 2003; 124:1240-8.; PMID:12730865; http://dx.doi.org/10.1016/S0016-5085(03)00279-8.
11. Flanagan JM, Munoz-Alegre M, Henderson S, Tang T, Sun P, Johnson N, et al. Gene-body hypermethylation of ATM in peripheral blood DNA of bilateral breast cancer patients. Hum Mol Genet 2009; 18:1332-42.; PMID:19153073; http://dx.doi.org/10.1093/hmg/ddp033.
12. Iwamoto T, Yamamoto N, Taguchi T, Tamaki Y, Noguchi S. BRCA1 promoter methylation in peripheral blood cells is associated with increased risk of breast cancer with BRCA1 promoter methylation. Breast Cancer Res Treat 2011; 129:69-77.; PMID:20882403; http://dx.doi.org/10.1007/s10549-010-1188-1.
13. Kaaks R, Stattin P, Villar S, Poetsch AR, Dossus L, Nieters A, et al. Insulin-like growth factor-II methylation status in lymphocyte DNA and colon cancer risk in the northern Sweden Health and Disease cohort. Cancer Res 2009; 69:5400-5.; PMID:19549920; http://dx.doi.org/10.1158/0008-5472.CAN-08-3020.
14. Leaderer D, Hoffman AE, Zheng T, Fu A, Weidhaas J, Paranjape T, et al. Genetic and epigenetic association studies suggest a role of microRNA biogenesis gene exportin-5 (XPO5) in breast tumorigenesis. Int J Mol Epidemiol Genet 2011; 2:9-18.; PMID:21552306.
15. Widschwendter M, Apostolidou S, Raum E, Rothenbacher D, Fiegl H, Menon U, et al. Epigenotyping in peripheral blood cell DNA and breast cancer risk: a proof of principle study. PLoS One 2008; 3:2656.; PMID:18628976; http://dx.doi.org/10.1371/journal.pone.0002656.
16. Wong EM, Southey MC, Fox SB, Brown MA, Dowty JG, Jenkins MA, et al. Constitutional methylation of the BRCA1 promoter is specifically associated with BRCA1 mutation-associated pathology in early-onset breast cancer. Cancer Prev Res (Phila) 2011; 4:23-33.; PMID:20978112; http://dx.doi.org/10.1158/1940-6207.CAPR-10-0212.
17. Fraga MF, Ballestar E, Paz MF, Ropero S, Setien F, Ballestar ML, et al. Epigenetic differences arise during the lifetime of monozygotic twins. Proc Natl Acad Sci USA 2005; 102:10604-10609.; PMID:16009939; http://dx.doi.org/10.1073/pnas.0500398102.
18. Bjornsson HT, Sigurdsson MI, Fallin MD, Irizarry RA, Aspelund T, Cui H, et al. Intra-individual change over time in DNA methylation with familial clustering. JAMA 2008; 299:2877-2883.; PMID:18577732; http://dx.doi.org/10.1001/jama.299.24.2877.
19. Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet 2001; 357:539-45.; PMID:11229684; http://dx.doi.org/10.1016/S0140-6736(00)04046-0.
20. Foran E, Garrity-Park MM, Mureau C, Newell J, Smyrk TC, Limburg PJ, et al. Upregulation of DNA methyltransferase-mediated gene silencing, anchorageindependent growth and migration of colon cancer cells by interleukin-6. Mol Cancer Res 2010; 8:471-81.; PMID:20354000; http://dx.doi.org/10.1158/1541-7786.MCR-09-0496.
21. Gasche JA, Hoffmann J, Boland CR, Goel A. Interleukin-6 promotes tumorigenesis by altering DNA methylation in oral cancer cells. Int J Cancer 2011; 129:1053-63.; PMID:21710491; http://dx.doi.org/10.1002/ijc.25764.
22. Wehbe H, Henson R, Meng F, Mize-Berge J, Patel T. Interleukin-6 contributes to growth in cholangiocarcinoma cells by aberrant promoter methylation and gene expression. Cancer Res 2006; 66:10517-24.; PMID:17079474; http://dx.doi.org/10.1158/0008-5472.CAN-06-2130.
23. Nile CJ, Read RC, Akil M, Duff GW, Wilson AG. Methylation status of a single CpG site in the IL6 promoter is related to IL6 messenger RNA levels and rheumatoid arthritis. Arthritis Rheum 2008; 58:2686-93.; PMID:18759290; http://dx.doi.org/10.1002/art.23758.
24. Issa JP. Age-related epigenetic changes and the immune system. Clin Immunol 2003; 109:103-8.; PMID:14585281; http://dx.doi.org/10.1016/S1521-6616(03)00203-1.
25. Terry MB, Delgado-Cruzata L, Vin-Raviv N, Wu HC, Santella RM. DNA methylation in white blood cells: association with risk factors in epidemiologic studies. Epigenetics 2011; 6:828-37.; PMID:21636973; http://dx.doi.org/10.4161/epi.6.7.16500.
26. El-Maarri O, Becker T, Junen J, Manzoor SS, Diaz-Lacava A, Schwaab R, et al. Gender specific differences in levels of DNA methylation at selected loci from human total blood: a tendency toward higher methylation levels in males. Hum Genet 2007; 122:505-14.; PMID:17851693; http://dx.doi.org/10.1007/s00439-007-0430-3.
27. Zhang FF, Cardarelli R, Carroll J, Fulda KG, Kaur M, Gonzalez K, et al. Significant differences in global genomic DNA methylation by gender and race/ethnicity in peripheral blood. Epigenetics 2011; 6:623-9.; PMID:21739720; http://dx.doi.org/10.4161/epi.6.5.15335.
28. Zhang FF, Morabia A, Carroll J, Gonzalez K, Fulda K, Kaur M, et al. Dietary patterns are associated with levels of global genomic DNA methylation in a cancer-free population. J Nutr 2011; 141:1165-1171.; PMID:21525250; http://dx.doi.org/10.3945/jn.110.134536.
29. McDowell MA, Lacher DA, Pfeiffer CM, Mulinare J, Picciano MF, Rader JI, et al. Blood folate levels: the latest NHANES results. NCHS Data Brief 2008; 1-8.
30. Zhang FF, Cardarelli R, Carroll J, Zhang S, Fulda KG, Gonzalez K, et al. Physical activity and global genomic DNA methylation in a cancer-free population. Epigenetics 2011; 6:293-9.; PMID:21178401; http://dx.doi.org/10.4161/epi.6.3.14378.
31. Zhu ZZ, Hou L, Bollati V, Tarantini L, Marinelli B, Cantone L, et al. Predictors of global methylation levels in blood DNA of healthy subjects: a combined analysis. Int J Epidemiol 2012; 41:126-39.; PMID:20846947; http://dx.doi.org/10.1093/ije/dyq154.
32. Yang AS, Estécio MR, Doshi K, Kondo Y, Tajara EH, Issa JP. A simple method for estimating global DNA methylation using bisulfite PCR of repetitive DNA elements. Nucleic Acids Res 2004; 32:38.; PMID:14973332; http://dx.doi.org/10.1093/nar/gnh032.
33. Bollati V, Baccarelli A, Hou L, Bonzini M, Fustinoni S, Cavallo D, et al. Changes in DNA methylation patterns in subjects exposed to low-dose benzene. Cancer Res 2007; 67:876-80.; PMID:17283117; http://dx.doi.org/10.1158/0008-5472.CAN-06-2995.
34. Tavares-Murta BM, Mendonça MA, Duarte NL, da Silva JA, Mutão TS, Garcia CB, et al. Systemic leukocyte alterations are associated with invasive uterine cervical cancer. Int J Gynecol Cancer 2010; 20:1154-1159.; PMID:21495217; http://dx.doi.org/10.1111/IGC.0b013e3181ef8deb.
35. Schmidl C, Klug M, Boeld TJ, Andreesen R, Hoffmann P, Edinger M, et al. Lineage-specific DNA methylation in T cells correlates with histone methylation and enhancer activity. Genome Res 2009; 19:1165-1174.; PMID:19494038; http://dx.doi.org/10.1101/gr.091470.109.
36. Wu HC, Delgado-Cruzata L, Flom JD, Kappil M, Ferris JS, Liao Y, et al. Global methylation profiles in DNA from different blood cell types. Epigenetics 2011; 6:76-85.; PMID:20890131; http://dx.doi.org/10.4161/epi.6.1.13391.
37. Cole BF, Baron JA, Sandler RS, Haile RW, Ahnen DJ, Bresalier RS, et al.; Polyp Prevention Study Group. Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA 2007; 297:2351-2359.; PMID:17551129; http://dx.doi.org/10.1001/jama.297.21.2351.
38. Figueiredo JC, Grau MV, Haile RW, Sandler RS, Summers RW, Bresalier RS, et al. Folic acid and risk of prostate cancer: results from a randomized clinical trial. J Natl Cancer Inst 2009; 101:432-5.; PMID:19276452; http://dx.doi.org/10.1093/jnci/djp019.
39. Ebbing M, Bønaa KH, Nygård O, Arnesen E, Ueland PM, Nordrehaug JE, et al. Cancer incidence and mortality after treatment with folic acid and vitamin B12. JAMA 2009; 302:2119-26.; PMID:19920236; http://dx.doi.org/10.1001/jama.2009.1622.
40. Morabia A, Zhang FF, Kappil MA, Flory J, Mirer FE, Santella RM, et al. Biologic and epigenetic impact of commuting to work by car or using public transportation: A case-control study. Prev Med 2012; 54:229-233.; PMID:22313796; http://dx.doi.org/10.1016/j.ypmed.2012.01.019.
41. Subar AF, Thompson FE, Kipnis V, Midthune D, Hurwitz P, McNutt S, et al. Comparative validation of the Block, Willett and National Cancer Institute food frequency questionnaires: the Eating at America's Table Study. Am J Epidemiol 2001; 154:1089-99.; PMID:11744511; http://dx.doi.org/10.1093/aje/154.12.1089.
42. Dong L, Block G, Mandel S. Activities Contributing to Total Energy Expenditure in the United States: Results from the NHAPS Study. Int J Behav Nutr Phys Act 2004; 1:4.; PMID:15169563; http://dx.doi.org/10.1186/1479-5868-1-4.
43. Block G, Jensen CD, Block TJ, Norris J, Dalvi TB, Fung EB. The work and home activities questionnaire: energy expenditure estimates and association with percent body fat. J Phys Act Health 2009; 6:61-9.; PMID:19998851.
44. Tucker KL. Dietary patterns, approaches and multicultural perspective. Appl Physiol Nutr Metab 2010; 35:211-8.; PMID:20383235; http://dx.doi.org/10.1139/H10-010.
45. Fogli-Cawley JJ, Dwyer JT, Saltzman E, McCullough ML, Troy LM, Jacques PF. The 2005 Dietary Guidelines for Americans Adherence Index: development and application. J Nutr 2006; 136:2908-2915.; PMID:17056821.
46. Fogli-Cawley JJ, Dwyer JT, Saltzman E, McCullough ML, Troy LM, Meigs JB, et al. The 2005 Dietary Guidelines for Americans and insulin resistance in the Framingham Offspring Cohort. Diabetes Care 2007; 30:817-22.; PMID:17259479; http://dx.doi.org/10.2337/dc06-1927.
47. Fogli-Cawley JJ, Dwyer JT, Saltzman E, McCullough ML, Troy LM, Meigs JB, et al. The 2005 Dietary Guidelines for Americans and risk of the metabolic syndrome. Am J Clin Nutr 2007; 86:1193-201.; PMID:17921402.
48. Shankar A, Wang JJ, Rochtchina E, Yu MC, Kefford R, Mitchell P. Association between circulating white blood cell count and cancer mortality: a populationbased cohort study. Arch Intern Med 2006; 166:188-194.; PMID:16432087; http://dx.doi.org/10.1001/archinte.166.2.188.
49. Miller M, Zhan M, Havas S. High attributable risk of elevated C-reactive protein level to conventional coronary heart disease risk factors: the Third National Health and Nutrition Examination Survey. Arch Intern Med 2005; 165:2063-8.; PMID:16216995; http://dx.doi.org/10.1001/archinte.165.18.2063.